Viable quantitative PCR for assessing the response of Candida albicans to antifungal treatment.
about
Dead or alive: molecular assessment of microbial viabilityEffects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during ExacerbationA viability-linked metagenomic analysis of cleanroom environments: eukarya, prokaryotes, and viruses.Antimicrobial Activity of Rhoeo discolor Phenolic Rich Extracts Determined by Flow Cytometry.
P2860
Viable quantitative PCR for assessing the response of Candida albicans to antifungal treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Viable quantitative PCR for as ...... icans to antifungal treatment.
@en
Viable quantitative PCR for as ...... icans to antifungal treatment.
@nl
type
label
Viable quantitative PCR for as ...... icans to antifungal treatment.
@en
Viable quantitative PCR for as ...... icans to antifungal treatment.
@nl
prefLabel
Viable quantitative PCR for as ...... icans to antifungal treatment.
@en
Viable quantitative PCR for as ...... icans to antifungal treatment.
@nl
P2093
P2860
P1476
Viable quantitative PCR for as ...... bicans to antifungal treatment
@en
P2093
Gemma Agustí
Jordi Morató
Mariana Fittipaldi
P2860
P2888
P304
P356
10.1007/S00253-012-4524-Z
P407
P577
2012-11-07T00:00:00Z